Similar articles

• [Usefulness of tiapamil, a new calcium antagonist, in the treatment of essential arterial hypertension].

  Nieto J, Gutiérrez Rodero F, Miranda B, Alcázar JM, Gutiérrez Millet V, Ruilope LM, Rodicio JL. Nieto J, et al. Med Clin (Barc). 1985 Jul 6;85(6):225-7. Med Clin (Barc). 1985. PMID: 4033283 Spanish. No abstract available.
• [Clinical study of an antihypertensive combination].

  Leng-Lévy J, Aubertin J, Leng B, Mayeux A. Leng-Lévy J, et al. Bord Med. 1972 Jun;5(12):1487-9. Bord Med. 1972. PMID: 4651175 French. No abstract available.
• [Clinical evaluation of a new hypotensive drug combination].

  Castillo Higueras PL, Rodríguez Cuartero A, Rodríguez Cuartero F, Urbano Jiménez F, Peláez Redondo J. Castillo Higueras PL, et al. Rev Clin Esp. 1977 Oct 31;147(2):185-9. Rev Clin Esp. 1977. PMID: 601282 Spanish. No abstract available.
• [When and why to start drug therapy in essential hypertension].

  Oliva G, Fallani P, Mete A, Covello R, Avallone A. Oliva G, et al. Clin Ter. 1987 Oct 15;123(1):51-5. Clin Ter. 1987. PMID: 2972467 Review. Italian. No abstract available.
• [Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension].

  Tomov I. Tomov I. Vutr Boles. 1985;24(6):39-47. Vutr Boles. 1985. PMID: 3913145 Review. Bulgarian. No abstract available.